Mechanism of Action

Client: Corbus Pharmaceuticals Holdings, Inc.


Chronic inflammation is a harmful process in which the immune system remains active for prolonged periods of time. It can affect any organ in the body and contributes to a number of common as well as rare diseases. Research has demonstrated that targeting the cannabinoid receptor type II on immune cells can limit fibrosis and reduce inflammation.

Lenabasum is an investigational drug that is designed to specifically bind to these receptors. Once bound, the drug molecule works as an agonist, using the body’s own signals to activate the resolution of inflammation.

Award of Excellence

2019 Videographer Awards
Video Production – Animation

Award of Excellence

2018 AMI Conference

See also

Lipid Nano-Crystal Platform


The Role of IL-1⍺ in Inflammation


Our pride and reputation are in everything we deliver.

Visit our process page to see how our award winning animations get created.

Leave a Reply